Key result
The optimal management of patent ductus arteriosus in preterm infants remains debated, as current interventions do not appear to improve survival and may carry risks of harm.
Why the study?
Does pharmacological or surgical closure of patent ductus arteriosus improve survival and long-term outcomes in preterm infants?
Population
Preterm infants with patent or persistent ductus arteriosus (PDA)
Comparison
Pharmacological treatment or surgical ligation vs Conservative management or alternative…
Design
Review
Authors
Loading...
Does not support routine PDA closure in preterm infants; leaves open identification of subgroups that may benefit from intervention.
Does pharmacological or surgical closure of patent ductus arteriosus improve survival and long-term outcomes in preterm infants?
This review highlights the ongoing debate regarding PDA management in preterm infants, suggesting that the risks of aggressive pharmacological or surgical closure must be carefully weighed against the lack of clear survival benefits.
Bart Van Overmeire (2007) conducted a review in Patent ductus arteriosus (PDA). Medical treatment (indomethacin, ibuprofen) or surgical ligation was evaluated. The optimal management of patent ductus arteriosus in preterm infants remains debated, as current interventions do not appear to improve survival and may carry risks of harm.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: